Saleh Saleh

Dr. Saleh Saleh


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2023 in Cancers
Verified
Journal Article
Open access
PDF file
GCGian Luigi Canu
Gian Luigi Canu
FCFederico Cappellacci
Federico Cappellacci
AAAhmed Abdallah
Ahmed Abdallah
IEIslam Elzahaby
Islam Elzahaby
DFDavid Figueroa-Bohorquez
David Figueroa-Bohorquez
Fabio MedasFabio Medas
Fabio Medas
Indeterminate thyroid nodules (ITNs) are characterized by an expected malignancy ranging from 5% to 30%, with most patients undergoing a diagnostic, rather than therapeutic, operation. The aim of our study was to compare the approach to ITNs across different regions of the world. In this retrospective, multicentric, international study, according to the WHO classification, we identified the South East Asian Region (SEAR), the Americas Region (AMR), the Eastern Mediterranean Region (EMR), the Europe Region (EUR), and the Western Pacific Region (WPR). One high-volume thyroid centre was included for each region. Demographic, preoperative, and pathologic data were compared among the different regions. Overall, 5737 patients from five high-volume thyroid centres were included in this study. We found that the proportion of ITNs over the global activity for thyroid disease was higher in the EUR (37.6%) than in the other regions (21.1–23.6%). In the EMR, the patients were significantly younger (with a mean of 43.1 years) than in the other regions (range, 48.8–57.4 years). The proportion of lobectomy was significantly higher in the WPR, where 83.2% (114/137) of patients received this treatment, than in the other regions, where lobectomies were performed in 44.1–58.1% of patients. The pathological diagnosis of malignancy was significantly higher in the SEAR centre, being over 60%, than in centres of the other regions, where it ranged from 26.3% to 41.3%. The occurrence of lymph node metastases was higher in the WPR (27.8%), AMR (26.9%), and EMR (20%) centres than in the EUR and SEAR centres, where it was lower than 10%. In summary, we found in our study different approaches and outcomes in the diagnosis and treatment of ITNs among countries. Overall, almost 60% of patients with ITNs who underwent surgery actually presented a benign disease, potentially undergoing an unnecessary operation.

21 May 2019 in Indian Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
IMIslam H. Metwally
Islam H. Metwally
OHOmar Hamdy
Omar Hamdy
SSSaleh Saleh
Saleh Saleh
MEMohamed Elbadrawy
Mohamed Elbadrawy
DEDina M. Elsaid
Dina M. Elsaid

16 August 2023 in Asian Journal of Surgery
Verified
Journal Article
Open access
IEIslam A. Elzahaby
Islam A. Elzahaby
MHMohamed Hamdy
Mohamed Hamdy
EAEssam Attia Ali
Essam Attia Ali
MAMahmoud Abdelaziz
Mahmoud Abdelaziz
SSSaleh Saleh
Saleh Saleh
BRBasel Refky
Basel Refky
The purpose of this study is to evaluate the outcomes of endoscopic hemithyroidectomy (EH) performed via the modified unilateral axillo-breast approach (UABA) in patients with lactating and/or large ptotic breasts. Between 2019 and 2021, we studied the records of twenty-three eligible female patients with lactating and/or large ptotic breasts who were presented with benign unilateral thyroid nodule (s) and who were treated by EH using modified UABA at Mansoura University Oncology Center or Meet Ghamr oncology center. The demographic data, clinicopathological parameters, operative and the esthetic outcomes were collected and analyzed. Nine patients (39%) were lactating. All patients were obese (the mean BMI was 37.82 ± 4.37). All patients were having large breasts, cup C and D sizes (34% of patients & 56% of patients respectively), except for only two lactating female patients who had Cup B breasts. All patients were having ptotic breasts. The thyroid nodules greatest dimension ranged from 2.1-6 cm. All procedures were completed successfully endoscopically without any perioperative adverse events except for one case with temporary hoarseness of voice and three cases with axillary port sites cellulitis. The mean operative time was 83.26 ± 7.92 min. The patient satisfaction scores were high. EH via modified UABA in patients with lactating and/or large ptotic breasts is safe, feasible and effective procedure without adverse events. It should be offered to this group of patients as an alternative to conventional open thyroidectomy if there is no other contraindication.

19 August 2026 in Discover Oncology
Verified
Journal Article
Open access
PDF file
AFAhmed M. Fareed
Ahmed M. Fareed
FSFarida A. Shokeir
Farida A. Shokeir
EAEssam Attia
Essam Attia
OHOmar Hamdy
Omar Hamdy
SSSaleh Saleh
Saleh Saleh
KAKhaled Mohamed Abdelwahab
Khaled Mohamed Abdelwahab
Introduction Estrogen receptor (ER) negative/progesterone receptor (PR) positive is an infrequently reported biological subtype of breast cancer (BC). Various authors have treated its existence doubtfully. To our knowledge, this study is the first within Egypt and the Middle East to investigate this rare subgroup of BC. Methods This retrospective study included all ER−/PR + BC patients treated in our center from 2016 to 2022. The collected data were coded, processed, and analyzed using IBM SPSS. Results The study included 149 patients with ER−/PR + breast cancer. The mean age was 50.3 years (21–83). The mean follow-up interval was 68 months. pT1 represented 20.8% of the cases, pT2 tumors were 50%, pT3 tumors were 16.7%, while pT4 tumors were 5.6%. As regards nodal staging, pN0 were 36.3%, pN1 24.7%, pN2 19.2%, and pN3 19.8%. The main histology of the tumors was infiltrating duct carcinoma (81.2%), followed by lobular carcinoma (8.7%). Weak PR positivity (Allred score < 6) was documented in 92 patients (61.7%). While the remaining patients showed strong PR positivity (scores of 6 or higher), 68% were HER2 receptor-negative. In the follow-up period, 39% of the patients suffered from disease relapse. The mean disease-free survival was 60.8 months, and the mean overall survival was 69.8 months. The nodal status was the only variable that significantly affected disease-free and overall survival in the univariate analysis, while no factor affected survival in the multivariate analysis. Conclusion ER−/PR + breast cancer seems to be an underestimated subtype, which is more aggressive than double-positive hormonal receptor breast cancer but less aggressive than double-negative hormonal receptor breast cancer.